Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sol Efroni

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 14

Top Venues

Scientific data

Scientific reports

NPJ precision oncology

Nature communications

Bar-Ilan University

Weizmann Institute of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bar-Ilan University Apr 1o 2009

Israel

Associate Professor :: Life Sciences

Education History

Weizmann Institute of Science

Israel

PHD :: Computer Science & Immunology

Publications

Tom Snir, Hagit Philip, Miri Gordin, Alona Zilberberg, Sol Efroni
The temporal behavior of the murine T cell receptor repertoire following Immunotherapy. Scientific data 10 (1) (2023)
Tom Snir, Hagit Philip, Miri Gordin, Alona Zilberberg, Sol Efroni
The temporal behavior of the murine T cell receptor repertoire following Immunotherapy. Scientific data 10 (1) (2023)
Tom Snir, Hagit Philip, Miri Gordin, Alona Zilberberg, Sol Efroni
The temporal behavior of the murine T cell receptor repertoire following Immunotherapy. Scientific data 10 (1) (2023)
Tom Snir, Hagit Philip, Miri Gordin, Alona Zilberberg, Sol Efroni
The temporal behavior of the murine T cell receptor repertoire following Immunotherapy. Scientific data 10 (1) (2023)
Tom Snir, Hagit Philip, Miri Gordin, Alona Zilberberg, Sol Efroni
The temporal behavior of the murine T cell receptor repertoire following Immunotherapy. Scientific data 10 (1) (2023)
Rotem Ben-Hamo, Adi Jacob Berger, Nancy S Gavert, Mendy Miller, Guy Pines, Roni Oren, Eli Pikarsky, Cyril H Benes, Tzahi Neuman, Yaara Zwang, Sol Efroni, Gad A Getz, Ravid Straussman
Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nature communications 11 (1) (2020)
Rivki Cashman, Alona Zilberberg, Avner Priel, Hagit Philip, Alexander Varvak, Avi Jacob, Irit Shoval, Sol Efroni
A single nucleotide variant of human PARP1 determines response to PARP inhibitors. NPJ precision oncology 4 (2020)
Orr Levy, Guy Amit, Dana Vaknin, Tom Snir, Sol Efroni, Peter Castaldi, Yang-Yu Liu, Haim Y Cohen, Amir Bashan
Age-related loss of gene-to-gene transcriptional coordination among single cells. Nature metabolism 2 (11) (2020)
Hadass R Jessel, Lior Aharoni, Sol Efroni, Ido Bachelet
A modeling algorithm for exploring the architecture and construction of bird nests. Scientific reports 9 (1) (2019)
Hadass R Jessel, Sagi Chen, Shmuel Osovski, Sol Efroni, Daniel Rittel, Ido Bachelet
Design principles of biologically fabricated avian nests. Scientific reports 9 (1) (2019)
Rotem Ben-Hamo, Alona Zilberberg, Helit Cohen, Keren Bahar-Shany, Chaim Wachtel, Jacob Korach, Sarit Aviel-Ronen, Iris Barshack, Danny Barash, Keren Levanon, Sol Efroni
Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types. NPJ precision oncology 3 (2019)
Adar Hacohen, Reuven Cohen, Sol Efroni, Baruch Barzel, Ido Bachelet
Digitizable therapeutics for decentralized mitigation of global pandemics. Scientific reports 9 (1) (2019)
Yinghua Zhu, Yujie Liu, Chao Zhang, Junjun Chu, Yanqing Wu, Yudong Li, Jieqiong Liu, Qian Li, Shunying Li, Qianfeng Shi, Liang Jin, Jianli Zhao, Dong Yin, Sol Efroni, Fengxi Su, Herui Yao, Erwei Song, Qiang Liu
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1. Nature communications 9 (1) (2018)
Dror Hibsh, Hadas Schori, Sol Efroni, Orit Shefi
De novo transcriptome assembly databases for the central nervous system of the medicinal leech. Scientific data 2 (2015)

Sol Efroni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sol Efroni